BIOVIAN has established itself as an experienced and knowledgeable GMP producer of Viral Vectors for gene therapy applications, immuno-oncology and vaccines with a goal to remove bottlenecks in gene therapy production with One-Stop-Shop CDMO services.
While academic groups and biopharmaceutical companies are scientifically highly experienced, they may lack the necessary process development, manufacturing, and regulatory knowledge for successful viral vector GMP production. We at Biovian are happy when we can support clients when they take their valuable molecules through the development and onto the market.
VIRAL VECTOR PRODUCTION FROM ALMOST ANY STARTING POINT
The building of Viral Vector processes from almost any starting point is the expertise of Biovian. We take pride in being able to help clients and start the Viral Vector project from a single vial of the virus or from a small volume of plasmid, if needed.
CHAPTERS:
0:00 An introduction to Viral Vector and gene therapy market
0:38 Reasons for the complexity of Viral Vector manufacturing
1:57 Biovian's expertise in Viral Vector production
2:52 Collaboration with Biovian - first steps
3:18 The benefits of selecting Biovian as a CDMO partner
LEARN MORE FROM OUR BLOGS:
-AAV production: [ Ссылка ]
-Viral Vector Process Development: [ Ссылка ]
CONTACT US: [ Ссылка ]
#Biovian #ViralVector #production
